It’s been 40 years since President Nixon’s “War on Drugs.” Is it possible that peace talks are now at hand? On Thursday, President Obama said the question of drug legalization and regulation is an ...

This Research Topic is part of the Insights in Experimental Pharmacology and Drug Discovery series. You can explore the ...

Drug-drug interactions (DDIs) remain a critical challenge in both clinical practice and the drug discovery process, given their potential to produce unforeseen adverse effects and compromise patient ...

Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...

A project that began as a Gates Foundation-funded effort to expand contraceptive options, particularly in developing nations, has led to the development of a new method to deliver certain drugs in ...

U.S. Food and Drug Administration (FDA) advisory committees play a key role in evaluating the efficacy and safety of new drugs. They include open public hearing sessions, whereby patients, clinicians, ...

The field of oncology has witnessed remarkable progress in the treatment of solid tumors, yet the quest for optimal therapeutic outcomes remains a formidable challenge. Current clinical evidence ...

The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as not of standard quality (NSQ)' in its ...